Carl Zeiss Meditec AG (CZMWY)
OTC: CZMWY
· Real-Time Price · USD
68.31
1.28 (1.91%)
At close: Jun 06, 2025, 3:58 PM
Carl Zeiss Meditec Cash Flow Statement
Financials in EUR. Fiscal
year is
October - September.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | n/a | n/a | 34.13M | 46.48M | 37.4M | 177.35M | 92.15M | 62M | 51M | 102.71M | 62.53M | 90.73M | 37.9M | 54.08M | 81.59M | 54.31M | 46.3M |
Depreciation & Amortization | n/a | n/a | n/a | 38.58M | n/a | 36.81M | n/a | 37.25M | n/a | 36.72M | n/a | 33.05M | n/a | 31.66M | n/a | 29.92M | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | -16.36M | n/a | 51.77M | n/a | -50.96M | n/a | 5.73M | n/a | 30K | n/a | 37.22M | n/a | 23.82M | n/a |
Other Non-Cash Items | -26.3M | 189.92M | -36.95M | -46.48M | -37.4M | 148.5M | -92.15M | 32.92M | -32.8M | -3.41M | -48.12M | -1.34M | -52.8M | 80.09M | -5.97M | 58.07M | -5.8M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 12.4M | n/a | n/a | n/a | -7.33M | n/a | n/a | n/a | 223K | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | -37.7M | n/a | -23.3M | n/a | -102.58M | n/a | -66.02M | n/a | -43.49M | n/a | 33.96M | n/a | 17.69M | n/a |
Operating Cash Flow | -26.3M | 189.92M | -2.82M | 59.22M | 1M | 203.06M | 55.6M | 29.6M | 18.2M | 99.3M | 14.42M | 89.38M | -14.9M | 134.16M | 75.62M | 112.38M | 40.5M |
Capital Expenditures | n/a | n/a | n/a | -80.15M | n/a | -61.52M | n/a | -52.34M | n/a | -46.64M | n/a | -35.34M | n/a | -42.84M | n/a | -23.26M | n/a |
Cash Acquisitions | n/a | n/a | n/a | 5K | n/a | -8.63M | n/a | -1.68M | n/a | -42.73M | n/a | -18.35M | n/a | -1.92M | n/a | -9.19M | n/a |
Purchase of Investments | n/a | n/a | n/a | -1.4M | n/a | n/a | n/a | -21.59M | n/a | -5.22M | n/a | -629K | n/a | -1.68M | n/a | -741K | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -17.6M | -56.2M | -371.11M | 96.56M | n/a | 32.36M | n/a | 19.6M | -19.6M | 64.19M | -64.19M | -38.31M | -16M | -31.4M | -19.01M | -13.09M | -11.7M |
Investing Cash Flow | -17.6M | -56.2M | -371.11M | 15.41M | -400K | -37.79M | 91.79M | -53.59M | -19.6M | -30.39M | -64.19M | -38.31M | -16M | -31.4M | -19.01M | -13.09M | -11.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -20.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | -98.2M | n/a | n/a | n/a | -98.39M | n/a | -80.5M | n/a | n/a | n/a | -44.72M | n/a | n/a | n/a |
Other Financial Acitivies | 50.1M | -147.85M | 393.45M | 26.15M | 2.7M | -41.69M | -124.18M | n/a | 17.7M | 8.96M | 51.63M | -49.73M | 31.4M | -110.49M | -50.74M | -99.06M | -21.6M |
Financial Cash Flow | 50.1M | -147.85M | 393.45M | -72.05M | 2.7M | -165.88M | -124.18M | 13.08M | 17.7M | -71.54M | 51.63M | -49.73M | 31.4M | -110.49M | -50.74M | -99.06M | -25.6M |
Net Cash Flow | n/a | n/a | 19.52M | -8.02M | 3.3M | -1.76M | 23.21M | -18.64M | 16.3M | -11.03M | 1.86M | 1.34M | 500K | -16.04M | 5.88M | 223K | 3.2M |
Free Cash Flow | -26.3M | 37.72M | -2.82M | -20.93M | 1M | 141.54M | 55.6M | -22.74M | 18.2M | 52.66M | 14.42M | 54.05M | -14.9M | 91.32M | 75.62M | 89.12M | 40.5M |